Walgreens Boots Alliance Inc. (NASDAQ: WBA) is a leading global retail pharmacy and healthcare company. The stock is trading down 60% from its 52-week high and with a stock performance down 58.5% ...

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

It isn't a bad business model, but the U.S. market is largely saturated. Competition is fierce, and more and more ways to buy medication now exist, exacerbating the issue. They include grocery stores, ...

WBA Stock Price Performance The retail pharmacy giant has struggled over the past month, with shares falling 22.5%, slightly trailing the industry’s 22% decline. The stock’s performance also ...

Walgreens stock is plunging, now down roughly 65% YTD. Walgreens's financials indicate a gross profit but far too much SG&A. Additionally, 25% of stores are unprofitable, and profitability is ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens will close 1,200 stores, impacting 13.79% of total locations, to restructure and improve financial health. Read more about recent earnings for this challenged pharmacy giant.

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.